These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 17067697)
1. Abnormal cardiac response to exercise in a murine model of familial hypertrophic cardiomyopathy. Nguyen L; Chung J; Lam L; Tsoutsman T; Semsarian C Int J Cardiol; 2007 Jul; 119(2):245-8. PubMed ID: 17067697 [TBL] [Abstract][Full Text] [Related]
2. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368 [TBL] [Abstract][Full Text] [Related]
3. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229 [TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene. Gomes AV; Potter JD Mol Cell Biochem; 2004 Aug; 263(1-2):99-114. PubMed ID: 15524171 [TBL] [Abstract][Full Text] [Related]
5. The L-type Ca(2+) channel facilitates abnormal metabolic activity in the cTnI-G203S mouse model of hypertrophic cardiomyopathy. Viola H; Johnstone V; Cserne Szappanos H; Richman T; Tsoutsman T; Filipovska A; Semsarian C; Hool L J Physiol; 2016 Jul; 594(14):4051-70. PubMed ID: 27062056 [TBL] [Abstract][Full Text] [Related]
6. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice. Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902 [TBL] [Abstract][Full Text] [Related]
7. Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease. Viola HM; Shah AA; Johnstone VPA; Cserne Szappanos H; Hodson MP; Hool LC Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23113-23124. PubMed ID: 32859761 [TBL] [Abstract][Full Text] [Related]
8. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849 [TBL] [Abstract][Full Text] [Related]
9. Familial hypertrophic cardiomyopathy mutations in troponin I (K183D, G203S, K206Q) enhance filament sliding. Köhler J; Chen Y; Brenner B; Gordon AM; Kraft T; Martyn DA; Regnier M; Rivera AJ; Wang CK; Chase PB Physiol Genomics; 2003 Jul; 14(2):117-28. PubMed ID: 12759477 [TBL] [Abstract][Full Text] [Related]
10. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy. Semsarian C; Healey MJ; Fatkin D; Giewat M; Duffy C; Seidman CE; Seidman JG J Mol Cell Cardiol; 2001 Nov; 33(11):2055-60. PubMed ID: 11708849 [TBL] [Abstract][Full Text] [Related]
11. Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Sanbe A; James J; Tuzcu V; Nas S; Martin L; Gulick J; Osinska H; Sakthivel S; Klevitsky R; Ginsburg KS; Bers DM; Zinman B; Lakatta EG; Robbins J Circulation; 2005 May; 111(18):2330-8. PubMed ID: 15867176 [TBL] [Abstract][Full Text] [Related]
12. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils. Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573 [TBL] [Abstract][Full Text] [Related]
13. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924 [TBL] [Abstract][Full Text] [Related]
14. Myocardial contractile and metabolic properties of familial hypertrophic cardiomyopathy caused by cardiac troponin I gene mutations: a simulation study. Wu B; Wang L; Liu Q; Luo Q Exp Physiol; 2012 Jan; 97(1):155-69. PubMed ID: 21967901 [TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout. Rajan S; Pena JR; Jegga AG; Aronow BJ; Wolska BM; Wieczorek DF Physiol Genomics; 2013 Sep; 45(17):764-73. PubMed ID: 23800848 [TBL] [Abstract][Full Text] [Related]
17. Genes, calcium and modifying factors in hypertrophic cardiomyopathy. Tsoutsman T; Lam L; Semsarian C Clin Exp Pharmacol Physiol; 2006; 33(1-2):139-45. PubMed ID: 16445713 [TBL] [Abstract][Full Text] [Related]
18. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629 [TBL] [Abstract][Full Text] [Related]
19. Computational simulation of hypertrophic cardiomyopathy mutations in troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i. Kataoka A; Hemmer C; Chase PB J Biomech; 2007; 40(9):2044-52. PubMed ID: 17140583 [TBL] [Abstract][Full Text] [Related]
20. Abnormal heart rate regulation in murine hearts with familial hypertrophic cardiomyopathy-related cardiac troponin T mutations. Jimenez J; Tardiff JC Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H627-35. PubMed ID: 21131475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]